Slovakia Pharmaceuticals and Healthcare Report Q4 2013

Business Monitor International Market Research Reports Market Reports Online XML Feed

Marketing on a budget? Join the waiting list for our newest ebook on How to Run Ads on an Entrepreneur's Budget. From our sponsors

Slovakia Pharmaceuticals and Healthcare Report Q4 2013 Sep 25th 2013, 00:00 Price: $ 1295   BMI View: Plans to unify the two largest, privately held health insurers into a unified single entity have faced delays and are stalling. Prime Minister Robert Fico's government wants to enact such a measure in 2015 instead of 2014 as planned originally, indicating that they are not taking it as seriously or are reconsidering. Moreover, the continued threat of parallel exports has forced Slovakia to roll back some harsh pricing controls. We forecast further generic uptake and greater co-payments by patients towards the cost of healthcare, in line with an established trend we see playing out in Eastern Europe. Headline Expenditure Projections ? Pharmaceuticals: EUR1.67bn (US$2.12bn) in 2012 to EUR1.67bn (US$2.22bn) in 2013; -0.2% in local currency terms and 4.5% in US dollar terms. Local curr ... Complete report details with Table of Contents and more @ http://www.marketreportsonline.com/278750.html

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions